Natural health product · NPN 80077945
Melatonin
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed May 31, 2017; licence last revised November 16, 2021.
- Natural Product Number (NPN)
- 80077945
- Dosage form
- Tablet
- Route
- Oral
- Licensing route
- CompendialThe company attested that the product meets a Health Canada monograph.
- First licensed
- May 31, 2017
- Licence last revised
- November 16, 2021
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide | 3 milligrams | Melatonin |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm).
Non-medicinal ingredients
Silicon dioxide; Calcium carbonate; Dextrose; Calcium phosphate, dibasic; Xylitol; Magnesium stearate; Stearic acid; D-Mannitol; Cellulose; Crospovidone